Your browser doesn't support javascript.
loading
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial.
Seydoux, Claire; Medinger, Michael; Gerull, Sabine; Halter, Joerg; Heim, Dominik; Chalandon, Yves; Levrat, Stavroula Masouridi; Schanz, Urs; Nair, Gayathri; Ansari, Marc; Simon, Patrick; Passweg, Jakob R; Cantoni, Nathan.
Afiliação
  • Seydoux C; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital of Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
  • Medinger M; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital of Basel, Petersgraben 4, CH-4031, Basel, Switzerland. michael.medinger@usb.ch.
  • Gerull S; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital of Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
  • Halter J; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital of Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
  • Heim D; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital of Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
  • Chalandon Y; Division of Hematology, Bone Marrow Transplant Unit, University Hospital of Geneva and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Levrat SM; Division of Hematology, Bone Marrow Transplant Unit, University Hospital of Geneva and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Schanz U; Department of Medical Oncology and Hematology, Stem-/Immune- cell-transplant Unit, University Hospital of Zurich, Zurich, Switzerland.
  • Nair G; Department of Medical Oncology and Hematology, Stem-/Immune- cell-transplant Unit, University Hospital of Zurich, Zurich, Switzerland.
  • Ansari M; Department Women, Children and Adolescent, Unit of Oncology and Hematology Pediatric, University Hospital of Geneva, Geneva, Switzerland.
  • Simon P; Cansearch Research Laboratory, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Passweg JR; Clinical Trials Unit, Department of Clinical Research, Basel University, Basel, Switzerland.
  • Cantoni N; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital of Basel, Petersgraben 4, CH-4031, Basel, Switzerland. jakob.passweg@usb.ch.
Ann Hematol ; 100(1): 209-216, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33098041
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bussulfano / Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Condicionamento Pré-Transplante / Ciclofosfamida / Imunossupressores Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça País de publicação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bussulfano / Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Condicionamento Pré-Transplante / Ciclofosfamida / Imunossupressores Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça País de publicação: Alemanha